Blood Bank Market Size, Share, Growth, and Industry Analysis, By Type (Blood (Whole Blood), Platelets, Plasma, Double Red Cells), By Application (Hospitals, Laboratories, Blood Centers, Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

BLOOD BANK MARKET OVERVIEW

The global Blood Bank Market size estimated at USD 18.26 billion in 2026 and is projected to reach USD 31.89 billion by 2035, growing at a CAGR of 6.39% from 2026 to 2035.

The Blood Bank Market plays a critical role in global healthcare systems, supporting trauma care, surgeries, cancer therapy, organ transplantation, and chronic disease management. More than 118 million blood donations are collected globally each year, while nearly 40% of total donations originate from high-income countries representing only 16% of the global population. Around 31 million blood components are transfused annually across North America, while Europe records over 25 million donations every year. Plasma-derived therapies increased by 11% in clinical utilization during 2024 due to rising immunodeficiency treatment demand. Automated blood collection systems accounted for 48% of installations in advanced healthcare facilities during 2025. Blood screening technologies achieved testing accuracy above 99%, strengthening transfusion safety standards globally.

The United States Blood Bank Market remains one of the largest globally, supported by more than 12,000 hospital-based and independent blood collection centers. Approximately 29,000 units of red blood cells, 5,000 platelet units, and 6,500 plasma units are required daily across the country. Nearly 13.6 million whole blood donations are collected annually in the United States, while trauma centers consume over 38% of emergency blood inventory. Automated blood processing systems are installed in 67% of major hospitals. The country also records more than 4.5 million patients receiving transfusions annually, with surgical procedures contributing 32% of total blood utilization during 2025.

KEY FINDINGS

LATEST TRENDS

The Blood Bank Market is experiencing rapid modernization due to rising healthcare digitization, increasing transfusion procedures, and growing adoption of automated blood management technologies. Automated donor screening systems accounted for 49% of new installations in blood centers during 2025, improving collection efficiency by 31%. Digital inventory monitoring platforms reduced blood wastage by 26% across large healthcare institutions. Platelet demand increased by 21% because of rising cancer treatment procedures and hematology disorders worldwide. Plasma collection volumes expanded by 18% during 2024 due to increasing use of immunoglobulin therapies.

Pathogen reduction technologies gained strong traction, with implementation rates increasing by 34% in developed healthcare markets. Artificial intelligence-assisted donor matching systems improved compatibility accuracy by 29%. Mobile blood donation units contributed 17% of total blood collection activities in urban regions during 2025. Hospitals also expanded emergency blood reserve capacity by 23% following increased trauma incidents and disaster preparedness initiatives. RFID-enabled blood tracking systems recorded adoption growth of 38%, significantly improving supply chain transparency. Blood component separation procedures represented 61% of overall processing activities globally, while centralized blood banking facilities handled 54% of total blood storage and distribution operations during 2025.

MARKET DYNAMICS

Driver

Rising demand for blood transfusions and surgical procedures.

The increasing number of surgeries, trauma cases, and chronic disease treatments continues to drive the Blood Bank Market significantly. More than 310 million major surgical procedures are performed globally each year, with blood transfusions required in nearly 32% of complex surgeries. Trauma injuries contribute to over 4.4 million deaths annually, increasing emergency blood demand by 28%. Cancer treatment procedures requiring platelet transfusions increased by 24% during 2025. Cardiovascular surgeries accounted for 19% of blood component utilization globally.

Restraint

Limited donor participation and blood wastage issues.

Blood shortages remain a major restraint affecting healthcare systems worldwide. Nearly 40% of low-income countries report inadequate blood supply availability for emergency treatment procedures. Donor participation rates declined by 14% in several urban regions during 2024 due to changing demographics and reduced volunteer engagement. Blood wastage reached 21% in facilities lacking advanced cold storage infrastructure. Platelets, which have a shelf life of only 5 days, contributed to 17% of total blood product losses. Rural healthcare institutions faced storage inefficiencies affecting 26% of collected blood inventory.

Expansion of automated blood collection and digital monitoring systems

Opportunity

Automation and digital healthcare technologies present substantial opportunities for the Blood Bank Market. Automated blood collection systems improved donor throughput by 33% and reduced processing time by 27% during 2025. RFID-enabled blood tracking solutions achieved 96% inventory accuracy in large healthcare institutions.

Artificial intelligence-based donor prediction systems increased donor retention by 24%. Emerging economies expanded blood banking infrastructure investments by 31% to improve healthcare accessibility.

Maintaining blood safety standards and storage efficiency

Challenge

Ensuring blood safety and maintaining efficient storage systems remain major challenges for blood bank operators. More than 12% of blood units are discarded annually due to contamination risks, temperature fluctuations, or expiration issues. Cold chain interruptions affected 18% of rural blood transportation networks during 2024.

Regulatory compliance requirements increased operational complexity by 25% across international blood banking operations. Blood screening laboratories faced shortages of trained personnel in 21% of developing healthcare markets.

•   
•   
  

  Download Free Sample to learn more about this report

    

BLOOD BANK MARKET SEGMENTATION

By Type

• Blood (Whole Blood): Whole blood remains the most utilized product segment in the Blood Bank Market, accounting for 43% of total transfusion procedures during 2025. Trauma centers consumed nearly 37% of whole blood supplies due to emergency treatment requirements. More than 118 million blood donations globally contributed significantly to whole blood inventory management. Surgical departments accounted for 29% of whole blood utilization in hospital settings. Whole blood collection procedures increased by 16% in Asia-Pacific healthcare facilities during 2024.

• Platelets: Platelets represented 18% of the Blood Bank Market during 2025, primarily driven by oncology treatments and hematological disorder management. Cancer patients accounted for 52% of platelet transfusion demand globally. Platelet apheresis procedures increased by 24% in advanced healthcare institutions due to rising leukemia treatment volumes. Hospitals expanded platelet storage capacities by 21% to manage emergency shortages. Automated platelet collection systems improved donor efficiency by 31% and reduced contamination risks significantly.

• Plasma: Plasma accounted for 29% of Blood Bank Market utilization during 2025 due to increasing demand for immunoglobulin therapies and coagulation factor treatments. Plasma-derived medicinal products recorded utilization growth of 22% globally. The United States contributed nearly 63% of total global plasma collection activities during 2025. Automated plasma collection technologies improved donor throughput by 34% across major plasma centers. Neurological disorder treatments accounted for 18% of plasma therapy utilization globally.

• Double Red Cells: Double red cell collection procedures represented 10% of the Blood Bank Market during 2025, supported by increasing demand for high-volume transfusion therapies. Automated apheresis technologies improved double red cell collection efficiency by 32%. Hospitals performing cardiovascular surgeries accounted for 27% of double red cell utilization globally. Donor retention rates increased by 18% through digital donor scheduling systems supporting specialized collection procedures. The United States recorded more than 1.2 million double red cell procedures during 2025.

By Application

• Hospitals: Hospitals dominated the Blood Bank Market with 51% application share during 2025 due to high surgical volumes and emergency transfusion requirements. More than 310 million surgeries annually contributed significantly to hospital blood demand worldwide. Intensive care units accounted for 23% of hospital transfusion procedures. Trauma centers increased blood inventory reserves by 26% following rising accident admissions. Digital blood tracking systems were installed in 58% of tertiary hospitals during 2025. Oncology departments represented 19% of hospital platelet utilization globally.

• Laboratories: Laboratories represented 14% of Blood Bank Market applications due to increasing demand for compatibility testing and infectious disease screening. Automated testing systems improved laboratory processing speed by 33% during 2025. Blood typing procedures increased by 18% globally because of rising surgical admissions. Molecular screening technologies achieved testing precision above 99% in advanced diagnostic facilities. Laboratories handling pathogen reduction testing expanded by 21% during 2024. Europe accounted for 31% of advanced blood testing laboratory operations globally.

• Blood Centers: Blood centers accounted for 27% of Blood Bank Market operations during 2025, supported by increasing voluntary donation campaigns and centralized collection infrastructure. More than 60% of blood collection activities globally were managed by centralized blood centers. Mobile donation units contributed 19% of total blood center collections during 2025. Automated donor screening systems improved operational efficiency by 28%. Blood centers expanded cold storage capacities by 23% to reduce product wastage.

• Others: The others segment, including research institutions and military healthcare systems, accounted for 8% of Blood Bank Market applications during 2025. Research organizations increased blood utilization for stem cell studies and immunological testing by 18%. Military healthcare facilities expanded emergency blood reserves by 21% due to disaster response preparedness. Academic institutions contributed 14% of transfusion research activities globally. Specialized clinics improved platelet therapy adoption by 16% during 2025. Government-supported healthcare campaigns increased blood donation awareness by 27% in developing economies.

•   
•   
  Download Free Sample to learn more about this report

    

BLOOD BANK MARKET REGIONAL OUTLOOK

• North America

North America dominated the Blood Bank Market with 39% share during 2025, supported by advanced healthcare infrastructure and strong donor participation networks. The United States recorded more than 13.6 million annual blood donations, while Canada contributed over 850,000 donations during 2025. Approximately 29,000 units of red blood cells are required daily across North American healthcare facilities.

Hospitals accounted for 54% of blood utilization in the region due to high surgical procedure volumes. Automated blood collection systems were installed in 67% of major hospitals and blood centers. Plasma collection activities increased by 18% because of rising immunoglobulin therapy demand. Trauma centers represented 24% of emergency transfusion procedures across the region.

• Europe

Europe accounted for 28% of the Blood Bank Market during 2025, driven by organized public healthcare systems and strong donor awareness programs. The region records more than 25 million blood donations annually, with voluntary unpaid donors contributing nearly 72% of total collections. Germany, France, and the United Kingdom represented 48% of regional transfusion activities.

Plasma-derived medicinal product utilization increased by 19% during 2025 because of rising neurological disorder treatments. Automated blood typing systems were adopted by 58% of regional laboratories. Hospitals represented 49% of blood utilization across Europe due to increasing cardiovascular and orthopedic surgeries.

• Asia-Pacific

Asia-Pacific represented 24% of the Blood Bank Market during 2025, supported by expanding healthcare infrastructure and rising patient populations. China, India, Japan, and South Korea accounted for 63% of regional blood collection activities. The region recorded more than 38 million annual blood donations during 2025. Government-supported awareness programs increased voluntary donor participation by 22% in urban healthcare systems.

Hospitals represented 53% of regional transfusion demand because of rising surgical procedures and trauma admissions. Automated blood processing adoption increased by 34% across major healthcare facilities. Plasma collection activities expanded by 18% due to growing demand for immunoglobulin therapies. India recorded over 14 million annual blood collections, while China expanded blood storage infrastructure by 26% during 2024.

• Middle East & Africa

Middle East & Africa accounted for 9% of the Blood Bank Market during 2025, supported by increasing healthcare investments and blood donation awareness initiatives. Saudi Arabia, South Africa, and the United Arab Emirates represented 46% of regional blood collection activities. Voluntary blood donations increased by 18% across urban healthcare systems during 2025.

Hospitals accounted for 51% of regional blood utilization because of rising trauma treatment demand and surgical admissions. Government healthcare modernization projects increased blood storage capacity by 22% during 2024. Automated blood screening technology adoption expanded by 16% across regional laboratories. Trauma-related emergency transfusions represented 27% of blood utilization in Middle Eastern healthcare facilities.

LIST OF TOP BLOOD BANK COMPANIES

• LFB Group
• Abbott
• Shire (Baxalta)
• Sichuan Yuanda Shuyang
• Grifols
• Kawasumi
• Bio-Rad Laboratories
• CBPO
• bioMérieux
• MacoPharma
• BD
• Japan Red Cross Society
• America’s Blood Centers
• CSL
• Octapharma
• Kedrion
• RAAS
• Cerus
• Fresenius Kabi
• Beckman Coulter
• American Red Cross
• BPL
• Biotest
• New York Blood Center
• Sanquin Blood Supply Foundation
• Ortho-Clinical
• Immucor
• Hualan Bio
• Canadian Blood Services
• Haemonetics
• Terumo BCT

List Of Top 2 Companies Market Share

• Grifols held approximately 18% share in global plasma collection and blood processing operations during 2025, supported by more than 390 plasma centers and expanded pathogen reduction technology deployment.
• CSL accounted for nearly 15% of global plasma-derived therapy and blood fractionation activities during 2025, supported by over 320 collection facilities and increased immunoglobulin production capacity.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investments in the Blood Bank Market increased significantly during 2025 due to rising healthcare modernization and transfusion safety requirements. Governments expanded national blood reserve infrastructure spending by 24% to strengthen emergency preparedness capabilities. Automated blood collection equipment installations increased by 31% across large healthcare facilities. Plasma collection center expansion projects contributed 27% of regional healthcare investment activity in North America and Europe. Artificial intelligence-enabled donor management systems improved donor retention by 22%, encouraging additional digital healthcare funding.

Emerging economies increased healthcare infrastructure investments by 29% to improve rural blood banking accessibility. Cold chain logistics modernization projects reduced blood wastage by 16% during 2025. Mobile blood donation campaigns expanded by 21% across densely populated urban regions. Plasma-derived therapy demand increased by 18%, creating opportunities for fractionation facilities and specialized plasma collection centers. Strategic collaborations between hospitals and independent blood banks improved transfusion efficiency by 19%.

NEW PRODUCT DEVELOPMENT

New product development in the Blood Bank Market is increasingly focused on automation, pathogen safety, and digital monitoring technologies. Automated blood separation devices improved processing speed by 28% during 2025 while reducing manual handling errors by 19%. AI-powered donor screening systems achieved compatibility accuracy above 98%, improving transfusion safety standards significantly. Portable blood storage units with real-time temperature monitoring reduced transportation losses by 17%.

Manufacturers introduced advanced pathogen reduction systems capable of lowering contamination risks by 31% during platelet and plasma processing. RFID-enabled blood bags improved inventory traceability by 36% across major healthcare institutions. Smart blood refrigerators with automated alerts reduced storage-related wastage by 14% during 2025. Digital donor engagement applications increased repeat donor participation by 23% through personalized scheduling and health tracking features. Rapid blood typing devices reduced emergency transfusion preparation time by 27%.

FIVE RECENT DEVELOPMENTS (2023-2025)

• Grifols expanded plasma collection capacity by 18% during 2024 through additional donor centers across North America and Europe.
• Cerus increased pathogen reduction technology deployment by 26% in hospital blood banks during 2025.
• Haemonetics launched upgraded automated blood collection systems improving donor throughput by 21% during 2024.
• Terumo BCT introduced advanced platelet collection technology reducing processing time by 17% during 2025.
• Abbott enhanced molecular blood screening platforms achieving testing precision above 99% during 2024 healthcare deployments.

BLOOD BANK MARKET REPORT COVERAGE

The Blood Bank Market report provides comprehensive analysis of blood collection, processing, storage, transfusion, and plasma therapy operations across major healthcare regions. The report covers whole blood, platelets, plasma, and double red cell product segments with detailed insights into utilization trends and operational performance. Hospitals accounted for 51% of total application demand during 2025, while blood centers represented 27% of market activity globally. Regional analysis includes North America, Europe, Asia-Pacific, and Middle East & Africa with detailed facts regarding donor participation, transfusion procedures, and healthcare infrastructure development.

The report evaluates technological advancements including automated blood collection systems, pathogen reduction technologies, RFID-enabled inventory management, and AI-assisted donor matching platforms. Digital monitoring systems improved inventory accuracy by 32%, while automated processing technologies increased collection efficiency by 28% during 2025. The report also examines investment trends, product innovation strategies, plasma therapy demand expansion, and blood safety regulations. Competitive analysis includes major companies operating in plasma collection, blood screening, transfusion diagnostics, and automated blood processing technologies across global healthcare systems.